4833M 15 850 (Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg)

Pill imprint 4833M 15 850 has been identified as Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg.

Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 850 mg / 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 4833M 15 850

Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg 4833M 15 850
Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg 4833M 15 850
Metformin hydrochloride and pioglitazone hydrochloride
Imprint:
4833M
15 850
Strength:
850 mg / 15 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)